Outcomes after chimeric antigen receptor T-cell therapy across large B-cell lymphoma subtypes

被引：0

作者：

Bourlon, Christianne ^{[1
]}

Roddie, Claire ^{[2
,3
]}

Menne, Tobias ^{[4
]}

Norman, Jane ^{[5
]}

O'Reilly, Maeve ^{[2
]}

Gibb, Adam ^{[6
]}

Besley, Caroline ^{[7
]}

Chaganti, Sridhar ^{[8
]}

Arias, Carlos Gonzalez ^{[9
]}

Jones, Ceri ^{[10
]}

Dikair, Abdalla ^{[11
]}

Allen, Sharon ^{[12
]}

Seymour, Frances ^{[13
]}

Osborne, Wendy ^{[4
]}

Mathew, Amrith ^{[8
]}

Townsend, William ^{[2
]}

Patten, Piers E. M. ^{[1
,14
]}

Thoulouli, Eleni ^{[5
]}

Abdulgawad, Ahmed ^{[15
]}

Lugthart, Sanne ^{[7
]}

Sanderson, Robin ^{[1
]}

Kirkwood, Amy A. ^{[16
]}

Kuhnl, Andrea ^{[1
]}

机构：

[1] Kings Coll Hosp London, Dept Hematol, London, England

[2] Univ Coll London Hosp, Dept Hematol, London, England

[3] UCL, UCL Canc Inst, London, England

[4] Newcastle Univ, Freeman Hosp, Dept Hematol, Newcastle, England

[5] Manchester Royal Infirm, Dept Hematol, Manchester, England

[6] Christie Hosp, Dept Med Oncol, Manchester, England

[7] Univ Hosp Bristol & Weston, Dept Hematol, Bristol, England

[8] Queen Elizabeth Hosp, Dept Hematol, Birmingham, England

[9] Royal Marsden Hosp, Dept Hematol, London, England

[10] Univ Hosp Wales, Dept Hematol, Cardiff, England

[11] Queen Elizabeth Hosp, Dept Hematol, Glasgow, Scotland

[12] Cambridge Univ Hosp, Dept Hematol, Cambridge, England

[13] Leeds Teaching Hosp, Dept Hematol, Leeds, England

[14] Kings Coll London, Comprehens Canc Ctr, London, England

[15] Christie Hosp, Dept Hematol, Manchester, England

[16] UCL, UCL Canc Inst, CR UK & UCL Canc Trials Ctr, London, England

来源：

HAEMATOLOGICA | 2024年 / 109卷 / 08期

关键词：

D O I：

10.3324/haematol.2024.285010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2716 / 2720

页数：5

共 50 条

[31] Chimeric Antigen Receptor T-Cell Therapy in Elderly Patients with Relapsed or Refractory Large B-Cell Lymphoma: A Multicenter Study
Tun, Aung M.
Patel, Romil
St-Pierre, Frederique
Ouchveridze, Evguenia
Niu, Alex
Obasi, Jennifer
Rosenthal, Allison C.
Pophali, Priyanka A.
Fenske, Timothy S.
Karmali, Reem
Ahmed, Sairah
Johnston, Patrick B.
BLOOD, 2023, 142
[32] Health State Utilities for Adverse Events Associated with Chimeric Antigen Receptor T-Cell Therapy in Large B-Cell Lymphoma
Timothy A. Howell
Louis S. Matza
Monika P. Jun
Jacob Garcia
Annette Powers
David G. Maloney
PharmacoEconomics - Open, 2022, 6 : 367 - 376
[33] Bullous and Exanthematous Lesions Associated With Chimeric Antigen Receptor T-Cell Therapy in a Patient With Diffuse Large B-Cell Lymphoma
Hu, Yongxian
Zheng, Weiyan
Qiao, Jianjun
Cui, Qu
Zhu, Yuanyuan
Chang, Alex H.
Huang, He
JAMA DERMATOLOGY, 2020, 156 (09) : 1026 - 1028
[34] PAYER AND PRESCRIBER PERSPECTIVES ON CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPIES IN DIFFUSE LARGE B-CELL LYMPHOMA
Privolnev, Y.
Vinuesa, L.
VALUE IN HEALTH, 2019, 22 : S425 - S425
[35] Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas
Manzar, Gohar S.
Pinnix, Chelsea C.
Dudzinski, Stephanie O.
Marqueen, Kathryn E.
Cha, Elaine E.
Nasr, Lewis F.
Yoder, Alison K.
Rooney, Michael K.
Strati, Paolo
Ahmed, Sairah
Nze, Chijioke
Nair, Ranjit
Fayad, Luis E.
Wang, Michael
Nastoupil, Loretta J.
Westin, Jason R.
Flowers, Christopher R.
Neelapu, Sattva S.
Gunther, Jillian R.
Dabaja, Bouthaina S.
Wu, Susan Y.
Fang, Penny Q.
FRONTIERS IN IMMUNOLOGY, 2025, 16
[36] Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphoma
Steiner, Raphael E.
Banchs, Jose
Koutroumpakis, Efstratios
Becnel, Melody
Gutierrez, Cristina
Strati, Paolo
Pinnix, Chelsea C.
Feng, Lei
Rondon, Gabriela
Claussen, Catherine
Palaskas, Nicolas
Karimzad, Kaveh
Ahmed, Sairah
Neelapu, Sattva S.
Shpall, Elizabeth
Wang, Michael
Vega, Francisco
Westin, Jason
Nastoupil, Loretta J.
Deswal, Anita
HAEMATOLOGICA, 2022, 107 (07) : 1555 - 1566
[37] Chimeric antigen receptor T-cell therapy in rheumatology: B-cell depletion 2.0
Appalaneni, Rohith
Achanta, Nikhila
Mohan, Chandra
CURRENT OPINION IN RHEUMATOLOGY, 2024, 36 (02) : 126 - 133
[38] Brain FDG-PET findings in chimeric antigen receptor T-cell therapy neurotoxicity for diffuse large B-cell lymphoma
Morbelli, Silvia
Gambella, Massimiliano
Raiola, Anna Maria
Ghiggi, Chiara
Bauckneht, Matteo
Raimondo, Tania Di
Lapucci, Caterina
Sambuceti, Gianmario
Inglese, Matilde
Angelucci, Emanuele
JOURNAL OF NEUROIMAGING, 2023, 33 (05) : 825 - 836
[39] Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma
Lin, Richard J.
Lobaugh, Stephanie M.
Pennisi, Martina
Chan, Hei Ton
Batlevi, Yakup
Ruiz, Josel D.
Elko, Theresa A.
Maloy, Molly A.
Batlevi, Connie L.
Dahi, Parastoo B.
Hamlin, Paul A.
Giralt, Sergio A.
Hamlin, Paul A.
Mead, Elena
Noy, Ariela
Palomba, M. Lia
Santomasso, Bianca D.
Sauter, Craig S.
Scordo, Michael
Shah, Gunjan L.
Korc-Grodzicki, Beatriz
Kim, Soo Jung
Silverberg, Mari Lynne
Brooklyn, Chelsea A.
Devlin, Sean M.
Perales, Miguel-Angel
HAEMATOLOGICA, 2021, 106 (01) : 255 - 258
[40] Complete responses to odronextamab in two patients with diffuse large B-cell lymphoma refractory to chimeric antigen receptor T-cell therapy
Weinstock, Matt
Elavalakanar, Pavania
Bright, Susan
Ambati, Srikanth R.
Brouwer-Visser, Jurriaan
Pourpe, Stephane
Fiaschi, Nathalie
Jankovic, Vladimir
Thurston, Gavin
Deering, Raquel P.
Chaudhry, Aafia
Joyce, Robin
Arnason, Jon
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 199 (03) : 366 - 370

← 1 2 3 4 5 →